PL421576A1 - Pochodne pirazolo[1,5-a]pirymidyny jako inhibitory kinazy JAK - Google Patents
Pochodne pirazolo[1,5-a]pirymidyny jako inhibitory kinazy JAKInfo
- Publication number
- PL421576A1 PL421576A1 PL421576A PL42157617A PL421576A1 PL 421576 A1 PL421576 A1 PL 421576A1 PL 421576 A PL421576 A PL 421576A PL 42157617 A PL42157617 A PL 42157617A PL 421576 A1 PL421576 A1 PL 421576A1
- Authority
- PL
- Poland
- Prior art keywords
- group
- alkyl
- pyrazolo
- pyrimidine
- inhibitors
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Przedmiotem zgłoszenia jest związek o wzorze ogólnym (I), w którym R1 oznacza fenyl podstawiony jednym lub dwoma podstawnikami wybranymi z grupy składającej się z halogenu i alkoksylu C1-C3; 5- lub 6-członowy heteroaryl, który zawiera 1 lub 2 atomy N, niepodstawiony lub podstawiony podstawnikiem wybranym z grupy składającej się z -NH2, halogenu, alkilu C1-C4, dihalogenoalkilu C1-C4, alkoksylu C1-C3, 6-członowego heterocyklilu, który zawiera 1 lub 2 heteroatomy wybrane z grupy składającej się z N i O, i (6-członowy heterocyklilo)-(C1-C4)-alkilu, gdzie heterocyklil zawiera 1 lub 2 heteroatomy wybrane z grupy składającej się z N i O; lub 9-członowy bicykliczny heteroaryl, który zawiera 2 atomy N, podstawiony alkilem C1-C4, oraz jego sole addycyjne z kwasami. Związek znajduje zastosowanie jako lek w leczeniu przewlekłych chorób zapalnych i autoimmunologicznych.
Priority Applications (19)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL421576A PL233595B1 (pl) | 2017-05-12 | 2017-05-12 | Pochodne pirazolo[1,5-a]pirymidyny jako inhibitory kinazy JAK |
JP2019562296A JP7157084B2 (ja) | 2017-05-12 | 2018-05-10 | キナーゼJAK阻害剤としてのピラゾロ[1,5-a]ピリミジン誘導体 |
SI201830179T SI3621966T1 (sl) | 2017-05-12 | 2018-05-10 | Derivati pirazol(1,5-A)pirimidina kot kinazni JAK inhibitorji |
PT187235320T PT3621966T (pt) | 2017-05-12 | 2018-05-10 | Derivados de pirazole[1,5-a]pirimidina como inibidores de cinase jak |
EA201992632A EA038273B1 (ru) | 2017-05-12 | 2018-05-10 | Производные пиразоло[1,5-a]пиримидина в качестве ингибиторов киназы jak |
PCT/EP2018/062164 WO2018206739A1 (en) | 2017-05-12 | 2018-05-10 | Pyrazole[1,5-a]pyrimidine derivatives as kinase jak inhibitors |
MX2019013462A MX2019013462A (es) | 2017-05-12 | 2018-05-10 | Derivados de pirazolo[1,5-a]pirimidina como inhibidores de cinasas janus (jak). |
PL18723532T PL3621966T3 (pl) | 2017-05-12 | 2018-05-10 | Pochodne pirazolo[1,5-a]pirymidyny jako inhibitory kinazy JAK |
EP18723532.0A EP3621966B1 (en) | 2017-05-12 | 2018-05-10 | Pyrazole[1,5-a]pyrimidine derivatives as kinase jak inhibitors |
ES18723532T ES2845230T3 (es) | 2017-05-12 | 2018-05-10 | Derivados de pirazol[1,5-a]pirimidina como inhibidores de quinasa JAK |
CA3059829A CA3059829A1 (en) | 2017-05-12 | 2018-05-10 | Pyrazolo[1,5-a]pyrimidine derivatives as kinase jak inhibitors |
DK18723532.0T DK3621966T3 (da) | 2017-05-12 | 2018-05-10 | Pyrazol[1,5-a]pyrimidinderivater som kinase jak-inhibitorer |
US16/609,891 US11072619B2 (en) | 2017-05-12 | 2018-05-10 | Pyrazole[1,5-a] pyrimidine derivatives as kinase JAK inhibitors |
BR112019023480-2A BR112019023480A2 (pt) | 2017-05-12 | 2018-05-10 | derivados de pirazolo [1,5-a] pirimidina como inibidores de quinase jack |
HUE18723532A HUE052997T2 (hu) | 2017-05-12 | 2018-05-10 | JAK kináz inhibitor pirazol[1,5-a]pirimidin származékok |
CN201880030939.9A CN110612302B (zh) | 2017-05-12 | 2018-05-10 | 作为激酶JAK抑制剂的吡唑并[1,5-a]嘧啶衍生物 |
KR1020197034120A KR102533519B1 (ko) | 2017-05-12 | 2018-05-10 | 키나아제 jak 저해제로서 피라졸[1,5-a]피리미딘 유도체 |
AU2018265457A AU2018265457B2 (en) | 2017-05-12 | 2018-05-10 | Pyrazole(1,5-a)pyrimidine derivatives as kinase JAK inhibitors |
HRP20210021TT HRP20210021T1 (hr) | 2017-05-12 | 2021-01-07 | Derivati pirazol[1,5-a]pirimidina kao inhibitori jak kinaze |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL421576A PL233595B1 (pl) | 2017-05-12 | 2017-05-12 | Pochodne pirazolo[1,5-a]pirymidyny jako inhibitory kinazy JAK |
Publications (2)
Publication Number | Publication Date |
---|---|
PL421576A1 true PL421576A1 (pl) | 2018-11-19 |
PL233595B1 PL233595B1 (pl) | 2019-11-29 |
Family
ID=64104351
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL421576A PL233595B1 (pl) | 2017-05-12 | 2017-05-12 | Pochodne pirazolo[1,5-a]pirymidyny jako inhibitory kinazy JAK |
PL18723532T PL3621966T3 (pl) | 2017-05-12 | 2018-05-10 | Pochodne pirazolo[1,5-a]pirymidyny jako inhibitory kinazy JAK |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL18723532T PL3621966T3 (pl) | 2017-05-12 | 2018-05-10 | Pochodne pirazolo[1,5-a]pirymidyny jako inhibitory kinazy JAK |
Country Status (18)
Country | Link |
---|---|
US (1) | US11072619B2 (pl) |
EP (1) | EP3621966B1 (pl) |
JP (1) | JP7157084B2 (pl) |
KR (1) | KR102533519B1 (pl) |
CN (1) | CN110612302B (pl) |
AU (1) | AU2018265457B2 (pl) |
BR (1) | BR112019023480A2 (pl) |
CA (1) | CA3059829A1 (pl) |
DK (1) | DK3621966T3 (pl) |
EA (1) | EA038273B1 (pl) |
ES (1) | ES2845230T3 (pl) |
HR (1) | HRP20210021T1 (pl) |
HU (1) | HUE052997T2 (pl) |
MX (1) | MX2019013462A (pl) |
PL (2) | PL233595B1 (pl) |
PT (1) | PT3621966T (pl) |
SI (1) | SI3621966T1 (pl) |
WO (1) | WO2018206739A1 (pl) |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MXPA05002571A (es) * | 2002-09-04 | 2005-09-08 | Schering Corp | Pirazolopirimidinas como inhibidores de cinasa dependientes de ciclina. |
US7705153B2 (en) | 2004-02-05 | 2010-04-27 | Schering Corporation | Bipiperdine derivatives useful as CCR3 antagonists |
US7528138B2 (en) * | 2004-11-04 | 2009-05-05 | Vertex Pharmaceuticals Incorporated | Pyrazolo[1,5-a]pyrimidines useful as inhibitors of protein kinases |
KR20090106604A (ko) | 2007-01-12 | 2009-10-09 | 아스텔라스세이야쿠 가부시키가이샤 | 축합 피리딘 화합물 |
UA110324C2 (en) * | 2009-07-02 | 2015-12-25 | Genentech Inc | Jak inhibitory compounds based on pyrazolo pyrimidine |
AR077346A1 (es) | 2009-07-31 | 2011-08-17 | Biocryst Pharm Inc | Compuestos heterociclicos como inhibidores de janus quinasa |
CN102666545B (zh) * | 2009-10-20 | 2016-04-06 | 塞尔卓姆有限公司 | 作为jak抑制剂的杂环吡唑并嘧啶类似物 |
WO2012125886A1 (en) | 2011-03-17 | 2012-09-20 | Bristol-Myers Squibb Company | Pyrrolopyridazine jak3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases |
AR085435A1 (es) | 2011-03-17 | 2013-10-02 | Bristol Myers Squibb Co | Inhibidores de pirrolopiridazina jak3 y su uso para el tratamiento de enfermedades inflamatorias y autoinmunes |
UA111854C2 (uk) * | 2011-09-07 | 2016-06-24 | Інсайт Холдінгс Корпорейшн | Способи і проміжні сполуки для отримання інгібіторів jak |
ES2666353T3 (es) * | 2012-09-06 | 2018-05-04 | Bristol-Myers Squibb Company | Inhibidores de JAK3 de imidazopiridazina y su uso para el tratamiento de enfermedades inflamatorias y autoinmunitarias |
PL407081A1 (pl) * | 2014-02-05 | 2015-08-17 | Celon Pharma Spółka Akcyjna | Pochodne pirazolo[1,5-a]pirymidyny jako inhibitory kinazy JAK-2 |
-
2017
- 2017-05-12 PL PL421576A patent/PL233595B1/pl unknown
-
2018
- 2018-05-10 PT PT187235320T patent/PT3621966T/pt unknown
- 2018-05-10 WO PCT/EP2018/062164 patent/WO2018206739A1/en active Application Filing
- 2018-05-10 ES ES18723532T patent/ES2845230T3/es active Active
- 2018-05-10 CA CA3059829A patent/CA3059829A1/en active Pending
- 2018-05-10 BR BR112019023480-2A patent/BR112019023480A2/pt unknown
- 2018-05-10 SI SI201830179T patent/SI3621966T1/sl unknown
- 2018-05-10 JP JP2019562296A patent/JP7157084B2/ja active Active
- 2018-05-10 HU HUE18723532A patent/HUE052997T2/hu unknown
- 2018-05-10 DK DK18723532.0T patent/DK3621966T3/da active
- 2018-05-10 PL PL18723532T patent/PL3621966T3/pl unknown
- 2018-05-10 CN CN201880030939.9A patent/CN110612302B/zh active Active
- 2018-05-10 US US16/609,891 patent/US11072619B2/en active Active
- 2018-05-10 KR KR1020197034120A patent/KR102533519B1/ko active IP Right Grant
- 2018-05-10 AU AU2018265457A patent/AU2018265457B2/en active Active
- 2018-05-10 EP EP18723532.0A patent/EP3621966B1/en active Active
- 2018-05-10 MX MX2019013462A patent/MX2019013462A/es unknown
- 2018-05-10 EA EA201992632A patent/EA038273B1/ru unknown
-
2021
- 2021-01-07 HR HRP20210021TT patent/HRP20210021T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
CN110612302A (zh) | 2019-12-24 |
PL3621966T3 (pl) | 2021-06-28 |
SI3621966T1 (sl) | 2021-04-30 |
EP3621966A1 (en) | 2020-03-18 |
CA3059829A1 (en) | 2018-11-15 |
JP7157084B2 (ja) | 2022-10-19 |
EP3621966B1 (en) | 2020-11-18 |
MX2019013462A (es) | 2020-01-15 |
PT3621966T (pt) | 2021-01-20 |
DK3621966T3 (da) | 2021-01-18 |
ES2845230T3 (es) | 2021-07-26 |
KR102533519B1 (ko) | 2023-05-17 |
AU2018265457B2 (en) | 2022-06-30 |
EA038273B1 (ru) | 2021-08-03 |
CN110612302B (zh) | 2022-06-14 |
HRP20210021T1 (hr) | 2021-02-19 |
EA201992632A1 (ru) | 2020-04-13 |
JP2020519631A (ja) | 2020-07-02 |
US11072619B2 (en) | 2021-07-27 |
AU2018265457A1 (en) | 2019-10-24 |
PL233595B1 (pl) | 2019-11-29 |
US20200199128A1 (en) | 2020-06-25 |
KR20200005562A (ko) | 2020-01-15 |
HUE052997T2 (hu) | 2021-06-28 |
BR112019023480A2 (pt) | 2020-06-30 |
WO2018206739A1 (en) | 2018-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20230161A1 (es) | Inhibidores de proteinas kras mutantes | |
EA202191104A1 (ru) | Производные аминопиридина/пиразина в качестве ингибиторов ctps1 | |
EA202091475A1 (ru) | ПРОИЗВОДНЫЕ 5-(2-(2,5-ДИФТОРФЕНИЛ)ПИРРОЛИДИН-1-ИЛ)-3-(1H-ПИРАЗОЛ-1-ИЛ)ПИРАЗОЛО[1,5-а]ПИРИМИДИНА И РОДСТВЕННЫЕ СОЕДИНЕНИЯ В КАЧЕСТВЕ ИНГИБИТОРОВ Trk КИНАЗЫ ДЛЯ ЛЕЧЕНИЯ РАКА | |
PE20161066A1 (es) | Derivados de piperidinil-indol como inhibidores del factor de complemento b y usos de los mismos | |
PE20190656A1 (es) | Compuestos de tiazolo-piridina sustituida como inhibidores de malt1 | |
EA202092263A1 (ru) | Аминопиридиновые производные в качестве ингибиторов ctps1 | |
EA201592199A1 (ru) | Производные бипиразола в качестве ингибиторов jak | |
PE20150218A1 (es) | Nuevos derivados fosfatos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
PH12020500528A1 (en) | Pyrimidine compound as jak kinase inhibitor | |
UA116768C2 (uk) | Дизаміщені бензотієнілпіролотриазини та їх застосування як інгібіторів кінази рфрф | |
EA201790658A1 (ru) | Производные диарилмочевины в качестве ингибиторов киназы p38 | |
EA201591906A1 (ru) | Производные мочевины, полезные в качестве ингибиторов киназы | |
PE20120058A1 (es) | Derivados de imidazopirazina como inhibidores de syk | |
PH12020550143A1 (en) | Salts of pyrrolotriazine derivatives useful as tam inhibitors | |
EA201890663A1 (ru) | Соли ингибитора киназы pim | |
MX2020006614A (es) | Derivados de cromenopiridina como inhibidores de fosfatidilinositol fosfato cinasa,. | |
EA202190055A1 (ru) | Производные пиразола в качестве ингибиторов malt1 | |
PE20170640A1 (es) | Derivados de quinolizinona como inhibidores de pi3k | |
EA201790209A1 (ru) | Новые 2,5-замещенные пиримидины в качестве ингибиторов pde | |
ZA202106014B (en) | Solid forms of condensed pyrazines as syk inhibitors | |
MX2018010177A (es) | Compuestos de 6,7-dihidro-5h-pirazolo[5,1-b][1,3]oxazina-2-carboxa mida. | |
BR112018068213A2 (pt) | derivados indólicos e seu uso como inibidores de proteína quinase | |
EA201791743A1 (ru) | Производные имидазо[2,1-в]тиазола и 5,6-дигидроимидазо[2,1-в]тиазола, применяемые в качестве s100-ингибиторов | |
PL421576A1 (pl) | Pochodne pirazolo[1,5-a]pirymidyny jako inhibitory kinazy JAK | |
PL411864A1 (pl) | Pochodne 7-(morfolin-4-ylo)pirazolo[1,5-α]pirymidyny jako inhibitory kinazy P13 |